Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 4'-chloro-n-(1-isopropyl-4-piperidyl)-2-phenylacetanilide
2. Lorcainid
3. Lorcainide
4. Lorcainide Monohydrochloride
5. R 15889
6. R15889
7. Ro 13-1042
1. Lopantrol
2. Socainide Hydrochloride
3. Isocainide Hydrochloride
4. Lorcainide Hydrochloride [usan]
5. Einecs 261-504-6
6. N-(4-chlorophenyl)-2-phenyl-n-(1-propan-2-ylpiperidin-1-ium-4-yl)acetamide;chloride
7. Ro 13-1042
8. Lorivox
9. R 15889
10. 1t1s98onm1
11. 1313498-17-7
12. Benzeneacetamide, N-(4-chlorophenyl)-n-(1-(1-methylethyl)-4-piperidinyl)-, Monohydrochloride
13. Lorcainida Clorhidrato [spanish]
14. Lorcainida Clorhidrato
15. Unii-1t1s98onm1
16. N-(p-chlorophenyl)-n-(1-isopropylpiperidin-4-yl)phenylacetamide Hydrochloride
17. Nsc 310411
| Molecular Weight | 407.4 g/mol |
|---|---|
| Molecular Formula | C22H28Cl2N2O |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 5 |
| Exact Mass | 406.1578689 g/mol |
| Monoisotopic Mass | 406.1578689 g/mol |
| Topological Polar Surface Area | 24.8 Ų |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 433 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Anti-Arrhythmia Agents
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)
ABOUT THIS PAGE
A Lorcainide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lorcainide, including repackagers and relabelers. The FDA regulates Lorcainide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lorcainide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Lorcainide supplier is an individual or a company that provides Lorcainide active pharmaceutical ingredient (API) or Lorcainide finished formulations upon request. The Lorcainide suppliers may include Lorcainide API manufacturers, exporters, distributors and traders.
click here to find a list of Lorcainide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Lorcainide DMF (Drug Master File) is a document detailing the whole manufacturing process of Lorcainide active pharmaceutical ingredient (API) in detail. Different forms of Lorcainide DMFs exist exist since differing nations have different regulations, such as Lorcainide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Lorcainide DMF submitted to regulatory agencies in the US is known as a USDMF. Lorcainide USDMF includes data on Lorcainide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Lorcainide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Lorcainide suppliers with USDMF on PharmaCompass.
Lorcainide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Lorcainide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Lorcainide GMP manufacturer or Lorcainide GMP API supplier for your needs.
A Lorcainide CoA (Certificate of Analysis) is a formal document that attests to Lorcainide's compliance with Lorcainide specifications and serves as a tool for batch-level quality control.
Lorcainide CoA mostly includes findings from lab analyses of a specific batch. For each Lorcainide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Lorcainide may be tested according to a variety of international standards, such as European Pharmacopoeia (Lorcainide EP), Lorcainide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Lorcainide USP).
LOOKING FOR A SUPPLIER?
